Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Stocks - Dow Rebounds as Apple Rallies Into Earnings

Published 01/29/2020, 04:57 AM
Updated 01/29/2020, 05:12 AM
© Reuters.
US500
-
DJI
-
MMM
-
AAPL
-
PFE
-
MU
-
WDC
-
RTX
-
DAL
-
UAL
-
IXIC
-
SOX
-
AAL
-

By Yasin Ebrahim

Investing.com – The Dow rallied sharply Tuesday, as the rout a day earlier attracted bargain buying across stocks, even as the bulk of corporate earnings failed to live up to Wall Street expectations.

The S&P 500 rose 1%, while the Nasdaq Composite gained 1.4% and the Dow Jones Industrial Average rose 0.65%.

Bargain-hunting investors piled into beaten-down sectors like tech and travel stocks.

American Airlines (NASDAQ:AAL) and Delta Air Lines (NYSE:DAL) both ended in a day the green. But United Airlines (NASDAQ:UAL) proved an expectation to the rally after announcing that it was cutting some flights from the U.S. to mainland China, citing a "significant decline in demand as the (coronavirus) continues to spread."

The death toll from the coronavirus in China rose to 106, with 4,600 affected globally, according to media reports.

Tech also saw some reprieve, led by a rebound in semiconductor stocks with some on Wall Street suggesting the outbreak may pose a benefit to U.S.-based chip firms.

Any disruption to memory output in China on the back of a faster spread of the virus could "be positive for memory suppliers outside of China such as Micron (NASDAQ:MU), Western Digital (NASDAQ:WDC) and others," said Mizuho analyst Vijay Rakesh.

The Philadelphia Semiconductor Index ended the day more than 2% higher.

Apple (NASDAQ:AAPL) also supported the rally in the broader market, rising nearly 3% ahead of its fiscal first-quarter report due after the closing bell.

A wave of mostly bearish earnings, meanwhile, had little impact on sentiment.

3M (NYSE:MMM) slipped about 6% after the industrial giant reported quarterly results that fell short of Wall Street estimates. United Technologies (NYSE:UTX), however, beat quarterly estimates on both the top and bottom lines, sending its shares about 1% higher.

Pfizer (NYSE:PFE), meanwhile, fell 5% after its missed quarterly earnings estimates, driven partly by the loss of exclusivity for its pain drug Lyrica.

Sentiment on stocks was also underpinned by bullish economic data showing a sharp rise in consumer confidence.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.